Dror Lifshitz's research while affiliated with Tel Aviv University and other places

Publications (8)

Article
Full-text available
Background: Transgender men are a marginalized population with unique health care needs. However, their usage of health services is low because of considerable discrimination. A major factor in their avoidance is patient-provider interactions. Methods: This cross-sectional study included 102 transgender men who anonymously completed a 55-item qu...
Article
Research question What are the fertility preservation (FP) rates of transgender women and transgender men, and which factors affect their decision making? Design This prospective study included 97 transgender women and 91 transgender men referred to the Gender Clinic of our medical center's Endocrinology Institute and to the Gan Meir Community Hea...
Article
Research question Does Pfizer's Covid-19 vaccination detrimentally affect semen analysis parameters? Design We conducted a prospective cohort study in a single large tertiary center in Israel between February and March of 2021. Semen samples of 75 fertile men were analyzed 1-2 months following the second dose of Pfizer's covid-19 vaccine. The seme...
Article
Objective: To study the association of risk-reducing bilateral salpingo-oophorectomy (RRBSO) and breast cancer risk among BRCA pathogenic sequence variants (PSV). Methods: Jewish Israeli BRCA-carriers who underwent RRBSO were matched with those who did not - by the mutated gene and year of birth (±1 year). Breast cancer rates were compared. Res...
Article
Full-text available
Purpose To evaluate the correlation between urine protein/creatinine ratio (UPCR) and proteinuria in a 24-h urine collection and to calculate the predicative accuracy of different cutoffs of UPCR for the diagnosis of proteinuria. Methods A retrospective cohort study including women who admitted for the evaluation for suspected preeclampsia (PET) b...
Article
10548 Background: Uncertainty exists with regard to the role of bilateral salpingo-oophorectomy in altering the risk of breast cancer in BRCA-mutation carriers. Methods: Included were 1645 healthy Jewish Israeli BRCA1/2 -mutation carriers from a single center without prophylactic mastectomy. Carriers with and without risk-reducing bilateral salping...
Article
Objective To determine whether fertility treatments impact the risk of breast cancer in Jewish Israeli BRCA1/2 mutation carriers. Design Historical cohort study. Setting University-affiliated tertiary medical center. Patient(s) A total of 1,824 Jewish Israeli BRCA1/2 mutation carriers from a single center were stratified into 1,492 (81.8%) carri...
Article
To determine whether BRCA mutation carriers who undergo fertility treatments are at increased risk of developing invasive epithelial ovarian cancer (IEOC). Historical cohort study. Tertiary university-affiliated medical center and the National Cancer Registry. A total of 1,073 Jewish Israeli BRCA mutation carriers diagnosed in a single institution...

Citations

... One study reported that 67.4% of transgender women and 61.6% of transgender men had a desire to parent a child, with 50% and 37%, respectively, desiring a biological one. 8 Thus, fertility counseling early in the transition process can aid in attaining these goals. Health care providers should be sure to discuss all options with patients prior to hormone therapy or surgical intervention. ...
... Study bias was scaled as inferior quality (0-3 stars), medium quality (4-6 stars), and superior quality (7-9 stars). Disparities and disagreements were resolved by consensus (Table 1, Ref. [22,23,[25][26][27][28][29][30][31][32][33][34]). ...
... Gabriel et al. [68] examined 73 BRCA mutation carriers and reported that 17.6% of women who used ET and 31% women who did not use HRT developed breast cancer. Similarly, Perri et al. [69] examined 127 matched pairs with BRCA mutations and found that among all breast cancer cases, 20% used HRT and 28% did not (p = 0.178). The hormone status of the other participants was unclear [69]. ...
... After reviewing their titles and abstracts, 48 full-text articles containing potentially useful data were included for further evaluation. Of these, nine articles were finally qualified for meta-analysis [31][32][33][34][35][36][37][38][39]. The included studies were published between 2002 and 2021. ...
... In the present study, there was no statistically significant difference between primiparous, nulliparous, and multiparous groups in terms of median 24-h urine proteinuria and spot protein/creatinine ratios. However many studies suggest that testing and using spot urine protein/ creatinine ratio should not be associated with maternal age, gestational age, and parity (9,15,27). ...
... Of these, 10 investigated breast cancer risk, 9 evaluated ovarian cancer risk and 1 evaluated both breast and ovarian cancer risk. In total, 11 studies were included in the meta-analysis of breast cancer risk Narod et al., 2002;Gronwald et al., 2006;Haile et al., 2006;Brohet et al., 2007;Bernholtz et al., 2011;Kotsopoulos et al., 2014;Rieder et al., 2016;Park et al., 2017;Toss et al., 2017;Schrijver et al., 2018) and 10 studies were included in the analysis of ovarian cancer risk (Narod et al., 1998(Narod et al., , 2001Whittemore et al., 2004;Gronwald et al., 2006;Antoniou et al., 2009;Vicus et al., 2010a;Ferris et al., 2014;Kotsopoulos et al., 2015;Perri et al., 2015;Schrijver et al., 2021), as modified by contraceptive use. ...